“Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway”, IJBB, vol. 61, no. 11, pp. 639–658, Oct. 2024, doi: 10.56042/ijbb.v61i11.6391.